Google has announced a partnership with Abbott, a leading manufacturer of medical devices, to integrate continuous glucose monitoring (CGM) data into its Health app. This move comes after Google had previously acquired the company Lingo for $3 billion in 2020. Under this multi-year agreement, data from Abbott's Lingo CGM will be linked to the Google Health app.
The integration of Abbott's data is expected to enhance user experience and provide more personalized care options. Users with diabetes can now view their glucose trends alongside other health metrics, potentially leading to more informed decisions about medication and lifestyle adjustments. This partnership allows Google to expand its offerings in the healthcare industry, furthering its aim for a "digital health ecosystem".
The integration of Abbott's data is part of Google's ongoing push into AI-powered health coaching services. By leveraging Abbott's CGM technology, users will have access to more comprehensive health information and be able to work closely with their healthcare providers to develop tailored treatment plans. This collaboration is seen as a significant step towards creating a more integrated and user-centric approach to healthcare, one that can improve patient outcomes and satisfaction.